Appointment booking for Dr. Manuel Gigena, MD is currently not available.Dr. Manuel Gigena, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Manuel Gigena, MD (he/him) is a Surgeon in Mcminnville, OR with over 17 years of experience. What is your opinion of Dr. Manuel Gigena, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 17 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Manuel Gigena, MD has received over $9,087 which includes payments from the following companies:
$2,029.32 from Integra LifeSciences Corporation
$1,790.93 from Mentor Worldwide LLC
$1,527.03 from DePuy Synthes Sales Inc.
$1,199.60 from LifeCell Corporation
$966.02 from Bovie Medical Corporation
$653.51 from TEI Biosciences Inc
$153.28 from Allergan Inc.
$120.71 from Genentech USA, Inc.
$110.68 from Novadaq Technologies Inc.
$92.27 from Invuity, Inc.
$78.72 from Smith & Nephew, Inc.
$63.85 from Boston Scientific Corporation
$38.19 from Alliqua BioMedical, Inc.
$34.75 from Stryker Corporation
$31.22 from Medtronic Vascular, Inc.
$25.95 from KCI USA, Inc
$24.13 from AXOGEN
$23.14 from Ethicon US, LLC
$22.53 from Molnlycke Health Care US, LLC
$21.84 from Medline Industries, Inc.
Payments received by Dr. Manuel Gigena, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!